3/20/2008

Nanotechnology developer Arrowhead Research Corp. said Tuesday its Unidym subsidiary plans to spin off Ensysce Biosciences, which will focus on medical uses for carbon nanotubes, including for drug delivery.

Full Story:
CNNMoney

Related Summaries